Image
27.07.2023
Twelve Bridges, Ten Miles, One Amazing Challenge
A keen walker is taking on the challenge of our London Wellness Walk this year to help raise money for us...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more